These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24594691)

  • 1. Human phosphatidylethanolamine-binding protein 4 promoted the radioresistance of human rectal cancer by activating Akt in an ROS-dependent way.
    Qiu J; Yang G; Lin A; Shen Z; Wang D; Ding L
    PLoS One; 2014; 9(3):e90062. PubMed ID: 24594691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a chemical inhibitor of human phosphatidylethanolamine-binding protein 4 on radiosensitivity of rectal cancer cells.
    Qiu J; Tao Y; Yang G; Xu K; Lin AL; Li L
    World J Surg Oncol; 2016 Aug; 14(1):221. PubMed ID: 27553494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hPEBP4 as a predictive marker for the pathological response of rectal cancer to preoperative radiotherapy.
    Qiu J; Yang G; Shen Z; Xie Y; Wang L
    Int J Colorectal Dis; 2013 Feb; 28(2):241-6. PubMed ID: 22801881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphatidylethanolamine-binding protein 4 is associated with breast cancer metastasis through Src-mediated Akt tyrosine phosphorylation.
    Li H; Huang F; Fan L; Jiang Y; Wang X; Li J; Wang Q; Pan H; Sun J; Cao X; Wang X
    Oncogene; 2014 Sep; 33(37):4589-98. PubMed ID: 24276246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of human phosphatidylethanolamine-binding protein 4 enhances rituximab-induced death and chemosensitization in B-cell lymphoma.
    Wang K; Jiang Y; Zheng W; Liu Z; Li H; Lou J; Gu M; Wang X
    PLoS One; 2013; 8(2):e56829. PubMed ID: 23451095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of human phosphatidylethanolamine-binding protein 4 sensitizes breast cancer cells to tumor necrosis factor-alpha-induced apoptosis and cell growth arrest.
    Wang X; Li N; Li H; Liu B; Qiu J; Chen T; Cao X
    Clin Cancer Res; 2005 Oct; 11(20):7545-53. PubMed ID: 16243830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human phosphatidylethanolamine-binding protein 4 promotes transactivation of estrogen receptor alpha (ERalpha) in human cancer cells by inhibiting proteasome-dependent ERalpha degradation via association with Src.
    Liu H; Qiu J; Li N; Chen T; Cao X
    J Biol Chem; 2010 Jul; 285(29):21934-42. PubMed ID: 20460377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. hPEBP4 resists TRAIL-induced apoptosis of human prostate cancer cells by activating Akt and deactivating ERK1/2 pathways.
    Li H; Wang X; Li N; Qiu J; Zhang Y; Cao X
    J Biol Chem; 2007 Feb; 282(7):4943-4950. PubMed ID: 17178731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of tumor necrosis factor-alpha-induced tumor cell apoptosis by a small molecule inhibitor for anti-apoptotic protein hPEBP4.
    Qiu J; Xiao J; Han C; Li N; Shen X; Jiang H; Cao X
    J Biol Chem; 2010 Apr; 285(16):12241-7. PubMed ID: 20177075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel human phosphatidylethanolamine-binding protein resists tumor necrosis factor alpha-induced apoptosis by inhibiting mitogen-activated protein kinase pathway activation and phosphatidylethanolamine externalization.
    Wang X; Li N; Liu B; Sun H; Chen T; Li H; Qiu J; Zhang L; Wan T; Cao X
    J Biol Chem; 2004 Oct; 279(44):45855-64. PubMed ID: 15302887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-apoptotic hPEBP4 silencing promotes TRAIL-induced apoptosis of human ovarian cancer cells by activating ERK and JNK pathways.
    Li P; Wang X; Li N; Kong H; Guo Z; Liu S; Cao X
    Int J Mol Med; 2006 Sep; 18(3):505-10. PubMed ID: 16865237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistance-associated protein 3 confers resistance to chemoradiotherapy for rectal cancer by regulating reactive oxygen species and caspase-3-dependent apoptotic pathway.
    Yu Z; Zhang C; Wang H; Xing J; Gong H; Yu E; Zhang W; Zhang X; Cao G; Fu C
    Cancer Lett; 2014 Oct; 353(2):182-93. PubMed ID: 25088576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy.
    Shimura T; Kakuda S; Ochiai Y; Kuwahara Y; Takai Y; Fukumoto M
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):540-8. PubMed ID: 21398050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide.
    Lu L; Dong J; Wang L; Xia Q; Zhang D; Kim H; Yin T; Fan S; Shen Q
    Oncogene; 2018 Sep; 37(39):5292-5304. PubMed ID: 29855616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-kappaB activity.
    Sandur SK; Deorukhkar A; Pandey MK; Pabón AM; Shentu S; Guha S; Aggarwal BB; Krishnan S
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):534-42. PubMed ID: 19735878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serine/threonine kinase AKT is frequently activated in human bile duct cancer and is associated with increased radioresistance.
    Tanno S; Yanagawa N; Habiro A; Koizumi K; Nakano Y; Osanai M; Mizukami Y; Okumura T; Testa JR; Kohgo Y
    Cancer Res; 2004 May; 64(10):3486-90. PubMed ID: 15150102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factor ATF3 mediates the radioresistance of breast cancer.
    Zhao W; Sun M; Li S; Chen Z; Geng D
    J Cell Mol Med; 2018 Oct; 22(10):4664-4675. PubMed ID: 30117642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
    De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
    J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified HLA-A*0201-restricted CTL epitope from human oncoprotein (hPEBP4) induces more efficient antitumor responses.
    Sun W; Shi J; Wu J; Zhang J; Chen H; Li Y; Liu S; Wu Y; Tian Z; Cao X; Li N
    Cell Mol Immunol; 2018 Aug; 15(8):768-781. PubMed ID: 29375131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced RKIP enhances nasopharyngeal carcinoma radioresistance by increasing ERK and AKT activity.
    Yuan L; Yi HM; Yi H; Qu JQ; Zhu JF; Li LN; Xiao T; Zheng Z; Lu SS; Xiao ZQ
    Oncotarget; 2016 Mar; 7(10):11463-77. PubMed ID: 26862850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.